When the first GLP-1 RA, exenatide, was released in 2005, the sole indication was for glycemic control, and weight loss was deemed a favorable side effect
Any questions please call our office at 513-826-6142 Unlock Your Wellness Potential Reduce stress and anxiety, sharpen your focus, and enjoy a stable, balanced mood with our powerful MIC+B12 lipotropic injections
Aug 2018;50(6):e13033
doi: 10.2147/IMCRJ.S74563 [PubMed] 25873702 Janssen J, Singh-Saluja S
Research literature has explored its activity at melanocortin receptors and downstream signalling pathways involved in pigmentation biology
These medications are primarily prescribed to individuals with type 2 diabetes and those who are overweight or obese and have at least one weight-related health condition, such as high blood pressure or high cholesterol